EON Network: July 2024 Newsletter |
The EON monthly newsletter includes upcoming webinars, updates on exercise oncology and oncology nutrition related events, publications, and resources. This information is also available on the EON Network webpage. Past newsletters are archived here. General EON Network resources are listed here.
|
|
|
New Webinar Dates and Speakers Coming Soon |
|
|
| The newest editions of the EON Webinar Series will be announced soon — stay tuned!
Have a topic you'd like to hear about? Email eonnetwork@gwu.edu to let us know.
All previous webinar session recordings are available on the EON Network Webinars webpage.
|
|
|
Exercise Oncology and Oncology Nutrition Publications
|
|
|
|
Courneya KS. The emerging role of exercise as a cancer treatment. J Sport Health Sci 2024 Jul;13(4):443-444. PMID: 36935041. Read here.
|
|
|
Dr. Kerry Courneya writes "In this invited commentary, I discussed the growing interest and complexity in studying exercise as a cancer treatment. My primary point was to highlight the stark disconnect between the clinical treatment scenarios addressed by preclinical exercise studies versus those addressed by observational exercise studies. I further noted that both types of studies are currently limited in their utility to inform clinical exercise trials. To address this issue, I referenced a recent conference and subsequent publication that discussed the challenges and opportunities of conducting translational exercise oncology studies that better integrate animal and human research to maximize clinical advances. Finally, I briefly summarized a new framework that I have proposed to foster a more systematic and clinically-informed approach to the study of exercise as a cancer treatment."
|
Ford KL, Sawyer MB, Ghosh S, Trottier CF, Disi IR, Easaw J, Mulder K, Koski S, Porter Starr KN, Bales CW, Arends J, Siervo M, Deutz N, Prado CM. Feasibility of two levels of protein intake in patients with colorectal cancer: findings from the Protein Recommendation to Increase Muscle (PRIMe) randomized controlled pilot trial. ESMO Open 2024 Jun 26;9(7):103604. PMID: 38935990. Read here.
|
Gupta A, Kleckner IR, Lustberg MB. Exercise and physical medicine interventions for managing chemotherapy-induced peripheral neuropathy. JAMA Intern Med 2024 Jul 1. PMID: 38949805. Read here.
|
Moser R, Mayr NA, Nano J, Behzadi ST, Kiesl S, Combs SE, Borm KJ. A survey of cancer patients' interest in undertaking exercise to promote relaxation during radiotherapy for breast cancer and metastatic cancer. Radiat Oncol 2024 May 31;19(1):68. PMID: 38822369. Read here.
|
|
|
Call for Papers by the Journal of Sport and Health Science for a Special Issue on "Exercise as a Cancer Treatment" |
Papers appropriate for this special issue will examine exercise after a cancer diagnosis and report a clinical cancer outcome (e.g., cell/tumor growth, tumor response, disease recurrence, progression, death from cancer).
The deadline for submitting papers for this special issue is November 1, 2024.
|
|
|
NCI Notice of Special Interest (NOSI): Factors impacting how Time-Restricted Eating (TRE) influences cancer-related outcomes |
This Notice of Special Interest (NOSI) NOT-CA-24-073 is to promote studies examining the sustainability of TRE and the potential impact it may have on obesity and cancer across the cancer continuum.
Multiple principal investigators with the appropriate expertise are encouraged to apply. The first deadline is September 26, 2024.
|
|
|
NCI Notice of Special Interest (NOSI): Advancing Diet and Physical Activity Biomarkers for Assessing Lifestyle Interventions in Cancer Prevention and Cancer Interception Research |
|
|
This Notice of Special Interest (NOSI) NOT-CA-24-060 is to support applications improving diet and/or physical activity assessment biomarker development for evaluating lifestyle-based cancer prevention and interception approaches across diverse settings.
Multiple principal investigators with the appropriate expertise are encouraged to apply. The first deadline is October 5, 2024.
|
|
|
| - September 17, 2024
- Time: 2:00 - 3:00 PM ET
|
|
|
| - February 20-22, 2025 in Auckland, NZ
- Abstracts due August 16
|
|
|
| -
June 26 – 28, 2025 in Seattle, WA
- Abstract deadline (Scholarship application) due December 18, 2024
- Abstracts (Regular submission) due August 16
|
|
|
Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.
|
6110 Executive Blvd Suite 750 | Rockville, MD 20852 US
|
|
|
This email was sent to .
To continue receiving our emails, add us to your address book.
|
|
|
|